All Companies

TECH

Bio-Techne Corp.

Biological Products, (No Diagnostic Substances)

$72.03updated Jul 30, 2026

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Total Trades

12

Politicians Trading

3

Last Traded

Feb 24, 2026

Price history

Congressional Trades

PoliticianNotifiedTradedTypeAmountChange
April McClain DelaneyDMar 10, 2026Feb 24, 2026Sell$1,001 - $15,000+25.05%
April McClain DelaneyDFeb 2, 2026Jan 28, 2026Sell$1,001 - $15,000+9.87%
April McClain DelaneyDJan 5, 2026Dec 5, 2025Buy$1,001 - $15,000+16.78%
April McClain DelaneyDJan 5, 2026Dec 2, 2025Buy$1,001 - $15,000+14.42%
April McClain DelaneyDNov 4, 2025Oct 22, 2025Buy$1,001 - $15,000+12.92%
April McClain DelaneyDSep 2, 2025Aug 1, 2025Sell$1,001 - $15,000+31.23%
April McClain DelaneyDJul 2, 2025May 26, 2025Sell$1,001 - $15,000+53.98%
April McClain DelaneyDMay 2, 2025Apr 29, 2025Buy$1,001 - $15,000+42.63%
April McClain DelaneyDMay 2, 2025Apr 9, 2025Buy$1,001 - $15,000+33.22%
Robert BresnahanRMay 8, 2025Apr 8, 2025Sell$1,001 - $15,000+47.57%
Julie JohnsonDMay 14, 2025Apr 1, 2025Sell$1,001 - $15,000+25.60%
Robert BresnahanRMar 27, 2025Feb 25, 2025Buy$1,001 - $15,000+12.16%